Reuters logo
BRIEF-Achillion announces clinical milestone for the advancement of JNJ-4178
December 28, 2016 / 11:44 AM / 9 months ago

BRIEF-Achillion announces clinical milestone for the advancement of JNJ-4178

Dec 28 (Reuters) - Achillion Pharmaceuticals Inc

* Achillion announces clinical milestone for the advancement of JNJ-4178 in phase 2B development for chronic HCV

* Has received a $15 million milestone payment from Janssen Research & Development Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below